Client News: Eaton Peabody Represents PureTerra Ventures in $4 Million Capital Commitment to Sudoc

Eaton Peabody represented venture capital firm PureTerra Ventures, in its recent $4 Million capital commitment to Sudoc.

Sudoc is an innovative chemical industry startup developing a sustainable but powerful chemistry that can outperform toxic chemicals in many applications. TAML® molecules were invented at Carnegie Mellon University Institute for Green Science by Dr Terry Collins and his research teams based on a process of mimicking how enzymes work in the human liver. These TAML® molecules represent a new class of catalysts that make commonly available oxidants, such as hydrogen peroxide, exponentially more reactive and effective. Sudoc’s first brand, Dot – Dilute Oxidation Technology™ – uses this chemistry to address a series of difficult cleaning problems beginning with mold stains. Sudoc’s second brand NEAT™ – a New Environmental Approach to Treatment – is using this chemistry to treat water contaminants. Sudoc’s mission is to outperform toxic chemicals to remove them from our planet.

PureTerra is a venture capital fund focused on investing in disruptive water technologies with offices in Amsterdam Netherlands and Shanghai China. The fund combines strong entrepreneurial experience, a proven track record in driving sales and a vast network in the global water technology market. Key investors joining PureTerra in this round included Safar Partners, GiantLeap Capital and Freeflow. Learn more about PureTerra by visiting the website or by reaching out to

Eaton Peabody professionals Jeff Spaulding and Jen Baroletti represented PureTerra in the financing.

About Eaton Peabody
Eaton Peabody provides practical and cost-efficient guidance to startup and emerging companies and the investors that fund them. For more information, visit Eaton Peabody’s Startup and Emerging Companies webpage.